Loading
Latest filing published 11 Aug 2021 for Arch Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dan Yrigoyen has a single filing on record, published on 11 August 2021: a share grant in Arch Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration